Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC

NCT03629925 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

357

Enrollment

INDUSTRY

Sponsor class

Conditions

Squamous NSCLC

Interventions

DRUG: Sintilimab
DRUG: Gemcitabine
DRUG: Cisplatin
DRUG: Placebo
DRUG: Carboplatin

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.